Teva Establishes Four Pillars To Prop Up Its Return-To-Growth Strategy
Austedo And Uzedy Key To Near-Term Growth
New CEO Richard Francis outlined the company’s new focus on innovative brands, funded by a portion of capital reallocated from Teva’s generics business.